Innoviva (US.INVA)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.INVA · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 98.6% | → |
| ROE | 13.9% | ↑ |
| Cash Conversion | 18.9% | → |
| D/E Ratio | 0.20 | ↑ |
| Gross Margin | 84.1% | ↓ |
US.INVA (Innoviva) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY --------------------------- FCF Conversion 98.6% → ROE 13.9% ↑ Cash Conversion 18.9% → D/E Ratio 0.20 ↑ Gross Margin 84.1% ↓
Key Metrics
US.INVA (Innoviva) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY---------------------------FCF Conversion 98.6% →ROE 13.9% ↑Cash Conversion 18.9% →D/E Ratio 0.20 ↑Gross Margin 84.1% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies